Insulin and IGF-1 signalling: Longevity, protein homoeostasis and Alzheimer's disease

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 721-727

  O'Neill, Cora ^a   Kiely, Aoife P ^a   Coakley, Meghan F ^a   Manning, Sean ^a   Long Smith, Caitriona M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Alzheimer's disease; Amyloid; Insulin IGF 1 like signalling (IIS); Protein misfolding; Tau

Indexed keywords

AMYLOID BETA PROTEIN; EXENDIN 4; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LIRAGLUTIDE; MAMMALIAN TARGET OF RAPAMYCIN; OLIGOMER; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN C; TAU PROTEIN;

ALZHEIMER DISEASE; AUTOPHAGY; COGNITIVE DEFECT; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; FRAGILE X SYNDROME; LONG TERM DEPRESSION; LONG TERM POTENTIATION; LONGEVITY; MEMORY; MENTAL FUNCTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; HOMEOSTASIS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PROTEINS; TAU PROTEINS;

ANIMALIA; MAMMALIA;

EID: 84864395390     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120080     Document Type: Conference Paper

References (54)

1. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (Pubitemid 34790756)
2. Benilova, I., Karran, E. and De Strooper, B. (2012) The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-357
3. Holtzman, D.M., Morris, J.C. and Goate, A.M. (2011) Alzheimer's disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr71
4. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130
5. Braak, H. and Braak, E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357 (Pubitemid 27435070)
6. Boeve, B.F. and Hutton, M. (2008) Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol. 65, 460-464 (Pubitemid 351549953)
7. Ferreira, S.T. and Klein, W.L. (2011) The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 96, 529-543
8. Lee, V.M., Balin, B.J., Otvos, Jr, L. and Trojanowski, J.Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678 (Pubitemid 21916893)
9. Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D. et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650-3662 (Pubitemid 46557687)
10. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
11. Haass, C. (2010) Initiation and propagation of neurodegeneration. Nat. Med. 16, 1201-1204
12. Ittner, L.M. and Gotz, J. (2011) Amyloid-β and tau: a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72
13. McGeer, E.G. and McGeer, P.L. (2010) Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J. Alzheimer's Dis. 19, 355-361
14. Kenyon, C.J. (2010) The genetics of ageing. Nature 464, 504-512
15. Panowski, S.H. and Dillin, A. (2009) Signals of youth: endocrine regulation of aging in Caenorhabditis elegans. Trends Endocrinol. Metab. 20, 259-264
16. Douglas, P.M. and Dillin, A. (2010) Protein homeostasis and aging in neurodegeneration. J. Cell Biol. 190, 719-729
17. Franke, T.F. (2008) PI3K/Akt: getting it right matters. Oncogene 27, 6473-6488
18. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even, P.C., Cervera, P. and Le Bouc, Y. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187 (Pubitemid 36090987)
19. Wullschleger, S., Loewith, R. and Hall, M.N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484 (Pubitemid 43199434)
20. Cohen, E., Bieschke, J., Perciavalle, R.M., Kelly, J.W. and Dillin, A. (2006) Opposing activities protect against age-onset proteotoxicity. Science 313, 1604-1610 (Pubitemid 44414028)
21. Cohen, E., Paulsson, J.F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H.M., Holzenberger, M., Kelly, J.W. et al. (2009) Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157-1169
22. Freude, S., Hettich, M.M., Schumann, C., Stohr, O., Koch, L., Kohler, C., Udelhoven, M., Leeser, U., Muller, M., Kubota, N. et al. (2009) Neuronal IGF-1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J. 23, 3315-3324
23. Caccamo, A., Maldonado, M.A., Majumder, S., Medina, D.X., Holbein, W., Magri, A. and Oddo, S. (2011) Naturally secreted amyloid-β increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J. Biol. Chem. 286, 8924-8932
24. Caccamo, A., Majumder, S., Richardson, A., Strong, R. and Oddo, S. (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120
25. Majumder, S., Caccamo, A., Medina, D.X., Benavides, A.D., Javors, M.A., Kraig, E., Strong, R., Richardson, A. and Oddo, S. (2012) Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling. Aging Cell 11, 326-335
26. Khurana, V., Lu, Y., Steinhilb, M.L., Oldham, S., Shulman, J.M. and Feany, M.B. (2006) TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr. Biol. 16, 230-241 (Pubitemid 43190222)
27. Suh, Y., Atzmon, G., Cho, M.O., Hwang, D., Liu, B., Leahy, D.J., Barzilai, N. and Cohen, P. (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. U.S.A. 105, 3438-3442 (Pubitemid 351723571)
28. Bonafe, M., Barbieri, M., Marchegiani, F., Olivieri, F., Ragno, E., Giampieri, C., Mugianesi, E., Centurelli, M., Franceschi, C. and Paolisso, G. (2003) Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 88, 3299-3304 (Pubitemid 36877508)
29. van Heemst, D., Beekman, M., Mooijaart, S.P., Heijmans, B.T., Brandt, B.W., Zwaan, B.J., Slagboom, P.E. and Westendorp, R.G. (2005) Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4, 79-85 (Pubitemid 41632906)
30. Flachsbart, F., Caliebe, A., Kleindorp, R., Blanche, H., von Eller-Eberstein, H., Nikolaus, S., Schreiber, S. and Nebel, A. (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 106, 2700-2705
31. Frolich, L., Blum-Degen, D., Riederer, P. and Hoyer, S. (1999) A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann. N.Y. Acad. Sci. 893, 290-293 (Pubitemid 30038089)
32. Moloney, A.M., Griffin, R.J., Timmons, S., O'Connor, R., Ravid, R. and O'Neill, C. (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224-243
33. Steen, E., Terry, B.M., Rivera, E.J., Cannon, J.L., Neely, T.R., Tavares, R., Xu, X.J., Wands, J.R. and de la Monte, S.M. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease: is this type 3 diabetes? J. Alzheimer's Dis. 7, 63-80 (Pubitemid 40387185)
34. Ma, Q.L., Yang, F., Rosario, E.R., Ubeda, O.J., Beech, W., Gant, D.J., Chen, P.P., Hudspeth, B., Chen, C., Zhao, Y. et al. (2009) β-Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by ω-3 fatty acids and curcumin. J. Neurosci. 29, 9078-9089
35. Griffin, R.J., Moloney, A., Kelliher, M., Johnston, J.A., Ravid, R., Dockery, P., O'Connor, R. and O'Neill, C. (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 93, 105-117 (Pubitemid 40463520)
36. Zhang, X., Li, F., Bulloj, A., Zhang, Y.W., Tong, G., Zhang, Z., Liao, F.F. and Xu, H. (2006) Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules. FASEB J. 20, 1272-1274
37. Pei, J.J. and Hugon, J. (2008) mTOR-dependent signalling in Alzheimer's disease. J. Cell. Mol. Med. 12, 2525-2532
38. Townsend, M., Mehta, T. and Selkoe, D.J. (2007) Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 282, 33305-33312 (Pubitemid 350159548)
39. Zhao, W.Q., De Felice, F.G., Fernandez, S., Chen, H., Lambert, M.P., Quon, M.J., Krafft, G.A. and Klein, W.L. (2008) Amyloid β oligomers induce impairment of neuronal insulin receptors. FASEB J. 22, 246-260
40. De Felice, F.G., Vieira, M.N., Bomfim, T.R., Decker, H., Velasco, P.T., Lambert, M.P., Viola, K.L., Zhao, W.Q., Ferreira, S.T. and Klein, W.L. (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers. Proc. Natl. Acad. Sci. U.S.A. 106, 1971-1976
41. Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M. and Lamb, B.T. (2009) The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events. Mol. Neurodegener. 4, 14
42. Kwak, Y.D., Ma, T., Diao, S., Zhang, X., Chen, Y., Hsu, J., Lipton, S.A., Masliah, E., Xu, H. and Liao, F.F. (2010) NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol. Neurodegener. 5, 49
43. Chiang, H.C., Wang, L., Xie, Z., Yau, A. and Zhong, Y. (2010) PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 107, 7060-7065
44. Ehninger, D., de Vries, P.J. and Silva, A.J. (2009) From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J. Intellect. Disabil. Res. 53, 838-851
45. Peineau, S., Taghibiglou, C., Bradley, C., Wong, T.P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T. et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron 53, 703-717 (Pubitemid 46283369)
46. Hou, L. and Klann, E. (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24, 6352-6361 (Pubitemid 38944226)
47. Hoeffer, C.A. and Klann, E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75
48. Garelick, M.G. and Kennedy, B.K. (2011) TOR on the brain. Exp. Gerontol. 46, 155-163
49. Bear, M.F., Dolen, G., Osterweil, E. and Nagarajan, N. (2008) Fragile X: translation in action. Neuropsychopharmacology 33, 84-87 (Pubitemid 350191335)
50. Lee, E.K., Kim, H.H., Kuwano, Y., Abdelmohsen, K., Srikantan, S., Subaran, S.S., Gleichmann, M., Mughal, M.R., Martindale, J.L., Yang, X. et al. (2011) hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat. Struct. Mol. Biol. 17, 732-739
51. Craft, S., Baker, L.D., Montine, T.J., Minoshima, S., Watson, G.S., Claxton, A., Arbuckle, M., Callaghan, M., Tsai, E., Plymate, S.R. et al. (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29-38
52. Piriz, J., Muller, A., Trejo, J.L. and Torres-Aleman, I. (2011) IGF-I and the aging mammalian brain. Exp. Gerontol. 46, 96-99
53. McClean, P.L., Parthsarathy, V., Faivre, E. and Holscher, C. (2011) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J. Neurosci. 31, 6587-6594
54. Perry, T., Lahiri, D.K., Sambamurti, K., Chen, D., Mattson, M.P., Egan, J.M. and Greig, N.H. (2003) Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron. J. Neurosci. Res. 72, 603-612 (Pubitemid 36578646)